This article has Open Peer Review reports available.
Impact of removing mastoid process for advanced parotid cancer on facial nerve identification, preservation and reconstruction
© Yokoyama et al.; licensee BioMed Central Ltd. 2014
Received: 16 January 2014
Accepted: 26 February 2014
Published: 3 March 2014
Advanced parotid cancers more than 4 cm are firmly fixed around the main trunk of the facial nerve that can be hardly detected in narrow working space between mastoid process and parotid cancer. Even though facial nerve was preserved, facial nerve stretching during surgery has significantly serious effect on postoperative facial palsy.
To evaluate usefulness of removing mastoid process in managing advanced parotid cancers to contribute identifying and preserving facial nerve.
The study was performed on 18 advanced parotid cancers which was more than 4 cm and invaded around the facial nerve. Thirteen cases were fresh cases and 5 were recurrent cases.
According to a modified Blair incision, the sternocleidomastoid muscle is detached from the mastoid process with electrocautery. When the mastoid process is removed, the main trunk of the facial nerve can be observed from stylomastoid foramen.
This procedure was evaluated based on the duration of surgery, working space, and postoperative facial nerve function.
In eleven cases, facial nerves were sacrificed. Negative margins were achieved in 100% of the patients. The mean duration for removing of the mastoid process to identify facial nerves was 4.6 minutes. The mean size of the removed mastoid process was 2.1 cm in height and 2.3 cm in width, and 1.8 cm in depth. The extended mean working space was 16.0 cm3, and, as a result, the tumors could be resected without retraction.
Removing the mastoid process for advanced parotid tumors facilitates identification of the facial nerve and better preservation of the facial nerve function.
Advanced parotid cancers more than 4 cm are firmly fixed around the main trunk of the facial nerve that can be hardly detected in narrow working space between mastoid process and parotid gland with cancer. Though facial nerve is preserved, facial nerve stretching during surgery has significantly serious effect on postoperative facial palsy. Parotid cancers can spread along the nerve to the temporal bone proximally. However, temporal bone surgeries for managing parotid malignancies are not well reported.
To evaluate usefulness of removing mastoid process in managing advanced or recurrent parotid cancers to contribute identifying, preserving, and reconstructing facial nerve.
Patients and method
Patients and tumor characteristics
Carcinoma ex pleomorphic adenoma
Salivary duct carcinoma
squamous cell carcinoma
Acinic cell carcinoma
When the facial nerve has been already recognized as total paralysis, dissection is carried out along the main trunk of the facial nerve to the proximal intra-facial canal and distal to the cancer so that facial nerve reconstruction can be achieved after resection of the tumor. We accomplish this by removing the mastoid process and identifying the facial nerve in the vertical section of the temporal bone. Frozen examination of the proximal and distal nerve is checked prior to nerve reconstruction.
This procedure was evaluated based on the duration of surgery, working space, and postoperative facial nerve function using the House-Brackmann (HB) score.
Eighteen patients required either mastoidectomy (n: 15) or extended temporal bone resection (n: 3). In eleven cases, facial nerves were sacrificed. Theses facial nerves were reconstructed.
Negative margins were achieved in 100% of the patients.
Surgical procedure characteristics
Removing size of mass
4 cm — 8 cm
Period of removing mastoid tip and identifying facial nerve
Distance between cancer and mastoid process
postoperative HB scores
Preoperative each I, II, III, IV, V, and VI of H-B score was 4, 5, 2, 0, 3, 1 and 4, respectively.
Of the 7 patients in which the facial nerve was preserved, all 7 patients had almost normal facial function (HB I, II).
Facial nerve management is a crucial component of parotid surgery. Every effort should be made to preserve the facial nerve function. Removal of the mastoid process and careful dissection around the nerve in the stylomastoid foramen permits full exposure of the nerve as it passes through the facial canal. As a result, of the 7 patients in which the facial nerve was preserved, all 7 patients had almost normal facial function (HB I, II). However, according to our historical cohort (without mastoid procedure), the overall incidence of facial paralysis (HB > 1) was 100% for temporary and 20% for permanent deficits.
We indicated this mastoidectomy for locally advanced parotid cancers larger than 4 cm that invaded firmly around the parotid, recurrent large parotid cancers, and complete facial paralysis in order to identify facial nerves without stretching and maintaining surgical margins.
Tumors involving only the mastoid process can be safely managed with removal of the mastoid process. Because large rongeur bone forceps are more useful and safer than electrical burr for head and neck surgeon lacking otology technique.
When cancers involve the middle ear, removing the mastoid process and resection the temporal bone along the facial nerve facilitates resection of the middle ear cancer. Inadequate surgical margins have been reported in up to 63% of patients. Positive margins have been reported poor outcomes. Our study showed 100% negative margins in the patients.
This procedure enabled safe identification of the facial nerve, and facilitated reconstruction in facial nerve in patients with sacrificed facial nerves.
Removing the mastoid process for advanced parotid tumors facilitates identification of the facial nerve and, therefore, better preservation of the facial nerve function.
This study was supported in part by a Grant for Clinical Cancer Research from the Ministry of Health, Labor, and Welfare of Japan.
- Dulguerov P, Marchal F, Lehmann W: Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope. 1999, 109 (5): 754-762. 10.1097/00005537-199905000-00014.View ArticlePubMedGoogle Scholar
- House JW, Brackma DE: Facial nerve grading system. Otolaryngol Head Neck Surg. 1985, 93 (2): 146-147.PubMedGoogle Scholar
- Iyer NG, Clark JR, Murali R, Gao K, O’Brien CJ: Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual Disease: implications for facial nerve preservation. Head Neck. 2009, 31 (1): 21-27. 10.1002/hed.20912.View ArticlePubMedGoogle Scholar
- Garden AS, El-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ: Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997, 37 (1): 79-85. 10.1016/S0360-3016(96)00464-6.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.